Computational models and artificial intelligence accelerating drug discovery from years to months
Artificial intelligence and machine learning are revolutionizing every stage of drug discovery. From identifying disease targets to predicting drug interactions, AI systems can analyze vast datasets and find patterns that would take humans decades to discover.
Major pharmaceutical companies are investing billions in AI platforms, with some AI-discovered drugs already entering clinical trials in record time.
AI predicts 3D protein structures with 95% accuracy, solving a 50-year biology challenge
AI generates novel drug molecules optimized for specific targets and properties
ML identifies optimal patient populations and predicts trial outcomes
AI discovers new uses for existing approved drugs, accelerating time to market
Companies like Insilico Medicine, Recursion, Exscientia, and Insitro are pioneering AI drug discovery. Insilico achieved the first AI-designed drug to enter Phase 2 clinical trials, demonstrating the real-world impact of this technology.
Experience AI-powered drug discovery in our interactive lab
AI Discovery Lab Drug Predictor All Simulations